Exclusive interview highlights advances in yeast protein and yeast extracts, global expansion, sustainability, and future growth drivers

SHANGHAI, June 16, 2026 /PRNewswire/ -- Angel Yeast (SSE: 600298), a global yeast and biotech company, was interviewed by Food Ingredients, a leading international trade publication, in celebration of its 40th anniversary. Chairman Xiong Tao reviewed the company's 40-year development journey during the exclusive interview, shared perspectives on recent developments in yeast extracts and yeast protein, and discussed the company's global expansion, sustainability initiatives, and key growth drivers.

Over the past 40 years, Angel Yeast has helped make yeast products more widely available to consumers around the world through large-scale production and continuous innovation. This has not only modernized traditional fermentation processes but also made home baking easier and more accessible. The company has also expanded its expertise in yeast-derived ingredients, ranging from savory yeast extracts to yeast protein for nutrition applications. In yeast extracts, Angel Yeast applies biotechnology to help food manufacturers meet consumer demand for products that balance taste and nutrition. In yeast protein, its Angeopro product contains more than 80% protein and is widely recognized as a high-quality protein source.

"Yeast protein is becoming a new fermented protein source for the nutrition industry. It is moving toward large-scale application, expanding from traditional sectors such as baking, meat products, and dairy to emerging areas such as sports nutrition, foods for special medical purposes, and vegan foods. In the future, it is expected to see wider use around the world, and we are committed to making quality protein accessible and affordable for everyone," said Xiong Tao, Chairman of Angel Yeast.

Green Development: Circular Economy and ESG Practices

In 2025, Angel Yeast earned an EcoVadis Silver rating, placing the company among the top 15% of assessed organizations globally. The company has developed a circular production model in which agricultural raw materials are transformed into food ingredients, while production byproducts are returned to agriculture through value-added applications. At the same time, Angel Yeast has introduced renewable energy sources such as solar power and biomass, and established a full-life-cycle carbon footprint management system to ensure low-carbon production processes.

Global Expansion: Strengthening Local Presence and Customer Support

In an increasingly complex global business environment, Angel Yeast remains focused on providing reliable products and services to customers worldwide. To enhance responsiveness to the European market, the company has established an R&D center in Belgium to support the development of products tailored to local preferences. It is also building a new manufacturing facility in Indonesia to better serve customers across South Asia and other international markets.

"In the future, we will continue our overseas development philosophy of 'localizing for the local market,' bringing our supply chain closer to customers while also creating local jobs and supporting technological upgrading and industrial development," said Xiong Tao, Chairman of Angel Yeast.

Innovation as a Key Growth Driver

Across the yeast industry—from yeast extracts as natural flavoring solutions and yeast protein as a novel protein source to culture media for biopharmaceutical applications—significant opportunities for innovation remain.

"Innovation has always been at the heart of Angel Yeast's growth. As we look ahead, we will continue to strengthen our global manufacturing and R&D network, deepen our understanding of local markets, and invest in the capabilities needed to serve customers around the world. At the same time, we remain committed to attracting, developing, and retaining talented people, recognizing that their expertise and creativity are essential to the company's long-term success," said Xiong Tao, Chairman of Angel Yeast.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/angel-yeast-chairman-reflects-on-40-years-of-bringing-yeast-to-millions-of-households-worldwide-302801860.html

Die Zahl der Demenzerkrankungen in Deutschland könnte bis 2060 deutlich ansteigen und das Versorgungssystem spürbar unter Druck setzen. Nach neuen Prognosen des Wissenschaftlichen Instituts der AOK (WIdO) dürfte die Zahl der Betroffenen bei weiter steigender Lebenserwartung von derzeit rund 1,3 Millionen auf bis zu 2,1 Millionen zunehmen. Grundlage der Berechnungen ist ein kleinräumiges Prognoseverfahren, das das Institut gemeinsam mit den Universitäten Trier, Rostock und Köln entwickelt hat.

Die Analyse reicht hinunter bis auf die Ebene von 400 Kreisen und kreisfreien Städten und macht deutliche regionale Unterschiede sichtbar. Bereits 2020 lag der Anteil der Demenzkranken zwischen 1,0 Prozent in Tübingen und 2,6 Prozent in der brandenburgischen Prignitz. Für das Jahr 2060 erwarten die Forscher eine Spanne von 1,7 Prozent Demenzkranken in München bis zu 6,2 Prozent im Landkreis Elbe-Elster in Brandenburg. Besonders betroffen sind damit vor allem ländliche Regionen im Osten, die überdurchschnittlich altern.

Parallel zur wachsenden Zahl von Demenzfällen schrumpft der Pool potenzieller Pflege- und Betreuungspersonen im Erwerbsalter. Laut Studie kamen im Jahr 2020 rechnerisch noch 38 Menschen im erwerbsfähigen Alter auf einen Demenzfall. Bis 2060 dürfte dieses Verhältnis auf 21 Erwerbspersonen pro Fall sinken. Damit würden deutlich mehr Erkrankte von einer deutlich kleineren Zahl potenziell Erwerbstätiger versorgt werden müssen – mit entsprechenden Konsequenzen für Pflegeinfrastruktur, Kommunen und Sozialversicherungen.

Die Autoren der Studie betonen zugleich, dass der prognostizierte Anstieg nicht zwangsläufig ist. Nach heutigem wissenschaftlichem Stand lassen sich Demenzrisiken durch Prävention spürbar senken. Eine konsequentere Behandlung von Bluthochdruck und Diabetes, der Verzicht auf Rauchen oder ein höheres Bildungsniveau könnten dazu beitragen, etwa die Hälfte der Neuerkrankungen zu vermeiden. In einem solchen Szenario würde sich die Zahl der Demenzfälle im Jahr 2060 nicht weiter erhöhen, sondern sich auf einem Niveau zwischen 1,3 und 1,5 Millionen stabilisieren. Die Spannbreite der Projektionen zeigt damit, wie stark der künftige Versorgungsdruck von heute eingeleiteten Präventionsstrategien abhängen dürfte.